Inactivation of androgen-induced regulator ARD1 inhibits androgen receptor acetylation and prostate tumorigenesis
- 6 February 2012
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 109 (8), 3053-3058
- https://doi.org/10.1073/pnas.1113356109
Abstract
Androgen signaling through androgen receptor (AR) is critical for prostate tumorigenesis. Given that AR-mediated gene regulation is enhanced by AR coregulators, inactivation of those coregulators is emerging as a promising therapy for prostate cancer (PCa). Here, we show that the N-acetyltransferase arrest-defect 1 protein (ARD1) functions as a unique AR regulator in PCa cells. ARD1 is up-regulated in human PCa cell lines and primary tumor biopsies. The expression of ARD1 was augmented by treatment with synthetic androgen (R1881) unless AR is deficient or is inhibited by AR-specific siRNA or androgen inhibitor bicalutamide (Casodex). Depletion of ARD1 by shRNA suppressed PCa cell proliferation, anchorage-independent growth, and xenograft tumor formation in SCID mice, suggesting that AR-dependent ARD1 expression is biologically germane. Notably, ARD1 was critical for transcriptionally regulating a number of AR target genes that are involved in prostate tumorigenesis. Furthermore, ARD1 interacted physically with and acetylated the AR protein in vivo and in vitro. Because AR–ARD1 interaction facilitated the AR binding to its targeted promoters for gene transcription, we propose that ARD1 functions as a unique AR regulator and forms a positive feedback loop for AR-dependent prostate tumorigenesis. Disruption of AR–ARD1 interactions may be a potent intervention for androgen-dependent PCa therapy.Keywords
This publication has 26 references indexed in Scilit:
- Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell LinesMolecular Cancer Therapeutics, 2011
- Frequent Truncating Mutation of TFAM Induces Mitochondrial DNA Depletion and Apoptotic Resistance in Microsatellite-Unstable Colorectal CancerCancer Research, 2011
- HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progressionOncogene, 2011
- Regulation of Androgen-Responsive Transcription by the Chromatin Remodeling Factor CHD8Molecular Endocrinology, 2010
- ARD1 Stabilization of TSC2 Suppresses Tumorigenesis Through the mTOR Signaling PathwayScience Signaling, 2010
- Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humansProceedings of the National Academy of Sciences, 2009
- Generation of novel monoclonal antibodies and their application for detecting ARD1 expression in colorectal cancerCancer Letters, 2008
- A Hierarchical Network of Transcription Factors Governs Androgen Receptor-Dependent Prostate Cancer GrowthMolecular Cell, 2007
- Arrest-defective-1 Protein, an Acetyltransferase, Does Not Alter Stability of Hypoxia-inducible Factor (HIF)-1α and Is Not Induced by Hypoxia or HIFJournal of Biological Chemistry, 2005
- Interaction of N-Terminal Acetyltransferase with the Cytoplasmic Domain of -Amyloid Precursor Protein and Its Effect on A SecretionThe Journal of Biochemistry, 2005